The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health
Abstract
Objectives. Cost-utility analysis in which health benefits are quantified in terms of quality-adjusted life-years (QALYs) has now become the standard type of cost-effectiveness analysis. These studies are potentially influential in determining the extent of funding for particular pediatric interventions, and so their methodologic quality is extremely important. The objective of this study was twofold: first, to critically appraise published cost-utility analyses of interventions in child and adolescent health care in terms of the methods used to derive QALYs and, second, to discuss unresolved methodologic issues that are pertinent to the measurement of QALYs in pediatric populations. Methods. A comprehensive search using computerized databases (including Medline, Embase, Econlit, and databases specific to economic evaluation), Web searches, and citation tracking was undertaken to identify cost-utility studies of interventions that were aimed at those who were younger than 16 years and published before April 2004. The methods of individual studies were compared with the recognized published guidelines of the US Panel on Cost-Effectiveness in Health and Medicine and the National Institute for Clinical Excellence in England and Wales, which recommend the use of a generic health state classification system (eg, Health Utility Index, EuroQol-5D), a choice-based valuation method (eg, standard gamble or time trade-off) and preferences of the general public in estimating QALYs. Studies therefore were categorized and evaluated according to the methods used to describe the health state, the valuation technique, and source of preferences. Results. Fifty-four studies were reviewed, 34 (63%) of which were published in the past 5 years. A generic health status classification instrument was used in 22 (35%) cases; the remainder developed study-specific health state descriptions or elicited preferences directly from patients or proxies. In 3 (5%) cases, sources were unclear. Preference weights were elicited using choice-based techniques in 28 (42%) cases, either as tariffs for health status classification instruments (17 cases) or by directly valuing health state descriptions or patient health (11 cases). Preferences of the general public were used in only 23 (37%) cases. Four studies aggregated QALYs for mother/child or parents/child pairs without giving any theoretical justification. Although there was an increasing tendency for studies to use generic health status classification instruments, choice-based methods, and preferences of the general public, the majority of studies still did not adhere to these standard recommendations even in the period between January 2000 and March 2004. Despite increasing standardization in the methods advocated for economic evaluation over the past 10 years, there remains extensive variation in the actual methods used by researchers to calculate QALYs for children and adolescents. It is unclear whether these results suggest poor practice or a set of positive (or reactive) choices made by analysts in a methodologically uncertain area in which specific guidance is lacking regarding how to address the complexities of pediatric outcomes within the QALY framework. Many aspects of QALY measurement in children are not yet fully developed. In particular, there is (1) a lack of appropriate health state classification instruments that take account of the dynamics of child development, (2) a lack of health state classification instruments for use in children and infants who are younger than 5 years, and (3) the need to understand fully the role of proxies for measuring and valuing child health. Additional research efforts are also required to develop methods that account for the health benefits of parents or caregivers of the child and to consider the implications of combining different forms of utility measurement in childhood and adulthood. Conclusions. Although variations from standard recommendations may be attributable to poor practice among researchers who are either unaware of these recommendations or choose not to follow them, they could equally be the result of attempts to make research more rigorous and more defensible than it might be if the standard recommendations were followed. There are 4 potential approaches to conducting cost-utility analysis in pediatric populations: (1) the explicit development of a generic instrument designed to be applicable across both child and adult populations (likely to be difficult in practice), (2) insistence on use of a generic instrument developed for adults, (3) the use of generic instruments specifically developed for children without being concerned about comparability with interventions aimed at adults, and (4) abandoning attempts to use single outcome measures that combine mortality with quality weights. In the absence of a clear way forward, it is suggested that an expert panel be convened to debate and further consider these potential solutions and recommendations for best practice and future research. In the interim, comparisons of the relative cost-effectiveness reported as cost per QALY gained across interventions for different diseases and populations should be treated with extreme caution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Quality of life and pharmacoeconomics in clinical trials
Spilker, B. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,862
Quality-of-life measures in chronic diseases of childhood
Eiser, C., & Morse, R. (2001) · Health Technology Assessment · doi:10.3310/hta5040 · Cited by 872
The Beaver Dam Health Outcomes study: Initial Catalog of Health-state Quality Factors
Fryback, D. G., Dasbach, E. J., Klein, R., Klein, B. E. K., Dorn, N., Peterson, K., & Martin, P. A. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300202 · Cited by 733
Economic Evaluation of Neonatal Intensive Care of Very-Low-Birth-Weight Infants
Boyle, M. H., Torrance, G. W., Sinclair, J. C., & Horwood, S. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082206 · Cited by 464
Economic valuation of informal care
van den Berg, B., Brouwer, W. B. F., & Koopmanschap, M. A. (2004) · The European Journal of Health Economics · doi:10.1007/s10198-003-0189-y · Cited by 435
Health Economic Guidelines—Similarities, Differences and Some Implications
Hjelmgren, J., Berggren, F., & Andersson, F. (2001) · Value in Health · doi:10.1046/j.1524-4733.2001.43040.x · Cited by 322
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Sanders, G. D., & Taira, A. V. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0901.020168 · Cited by 310
Cost-Utility Analysis of the Cochlear Implant in Children
Cheng, A. K. (2000) · JAMA · doi:10.1001/jama.284.7.850 · Cited by 279
Measuring Health-Related Quality of Life in Children and Adolescents
(2014) · Psychology Press eBooks · doi:10.4324/9781315821009 · Cited by 270
Child Health Services Research: Challenges and Opportunities
Forrest, C. B. (1997) · JAMA · doi:10.1001/jama.1997.03540460051032 · Cited by 220
The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997
Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A., & Bell, C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00007 · Cited by 208
Petrou, S. (2003) · Health Economics · doi:10.1002/hec.775 · Cited by 168
A cost-utility analysis of therapy for amblyopia
Membreno, J. H., Brown, M. M., Brown, G. C., Sharma, S., & Beauchamp, G. R. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01286-1 · Cited by 161
Doyle, L. W., & the Victorian Infant Collaborative Study Group (2004) · PEDIATRICS · doi:10.1542/peds.113.3.510 · Cited by 154
Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine
Prosser, L. A., Ray, G. T., O’Brien, M., Kleinman, K., Santoli, J. M., & Lieu, T. A. (2004) · PEDIATRICS · doi:10.1542/peds.113.2.283 · Cited by 126
Tengs, T. O., Osgood, N. D., & Chen, L. L. (2001) · Preventive Medicine · doi:10.1006/pmed.2001.0922 · Cited by 122
Varicella vaccination in England and Wales: cost-utility analysis
Brisson, M., & Edmunds, W. J. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.10.862 · Cited by 121
Cost-Benefit Analysis of Universal Tandem Mass Spectrometry for Newborn Screening
Schoen, E. J., Baker, J. C., Colby, C. J., et al. (2002) · PEDIATRICS · doi:10.1542/peds.110.4.781 · Cited by 115
A Cost-effectiveness Analysis of Newborn Hearing Screening Strategies
Kemper, A. R., & Downs, S. M. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.5.484 · Cited by 111
Venditti, L. N., Venditti, C. P., Berry, G. T., Kaplan, P. B., Kaye, E. M., Glick, H. A., & Stanley, C. A. (2003) · PEDIATRICS · doi:10.1542/peds.112.5.1005 · Cited by 111
Cost-Effectiveness of Treatment for Threshold Retinopathy of Prematurity
Brown, G. C., Brown, M. M., Sharma, S., Tasman, W. S., & Brown, H. C. (1999) · PEDIATRICS · doi:10.1542/peds.104.4.e47 · Cited by 103
The Cost-effectiveness of Air Bags by Seating Position
Graham, J. D., Thompson, K. M., Goldie, S. J., Seguí‐Gómez, M., & Weinstein, M. C. (1997) · JAMA · doi:10.1001/jama.1997.03550170048031 · Cited by 101
Keren, R., Pati, S., & Feudtner, C. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422020-00001 · Cited by 100
Insinga, R. P., Laessig, R. H., & Hoffman, G. L. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.128116 · Cited by 90
Bradlyn, A. S., Harris, C. V., Warner, J. E., Ritchey, A. K., & al, E. (1993) · Health Psychology · doi:10.1037//0278-6133.12.3.246 · Cited by 82
Cost-Effectiveness of a Trial of Labor After Previous Cesarean
CHUNG, A., Macario, A., El-Sayed, Y. Y., Riley, E. T., Duncan, B. W., & Druzin, M. L. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01355-2 · Cited by 81
Methylphenidate in children with hyperactivity: review and cost–utility analysis
Gilmore, A., & Milne, R. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.564 · Cited by 78
Prenatal Screening for Cystic Fibrosis Carriers: An Economic Evaluation
Rowley, P. T., Loader, S., & Kaplan, R. M. (1998) · The American Journal of Human Genetics · doi:10.1086/302042 · Cited by 71
Performance of the EuroQol in children with imperforate anus
Stolk, E. A., Busschbach, J. J. V., & Vogels, T. (2000) · Quality of Life Research · doi:10.1023/a:1008923029886 · Cited by 70
Are Methods for Estimating QALYs in Cost-Effectiveness Analyses Improving?
Neumann, P. J., Ƶinner, D. E., & Wright, J. C. (1997) · Medical Decision Making · doi:10.1177/0272989x9701700405 · Cited by 65
Regional variation in the cost effectiveness of childhood hepatitis A immunization
Jacobs, R. J., Greenberg, D. P., Koff, R. S., Saab, S., & Meyerhoff, A. S. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000091295.53969.6a · Cited by 61
Posttraumatic distress in childhood cancer survivors and their parents
Kazak, A. E. (1998) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(1998)30:1+<54::aid-mpo8>3.0.co;2-z · Cited by 54
Raising the quality of cost-utility analyses: lessons learnt and still to learn
Gerard, K., Smoker, I., & Seymour, J. (1999) · Health Policy · doi:10.1016/s0168-8510(98)00061-x · Cited by 54
Cost-Effectiveness of a Potential Vaccine for Coccidioides immitis
Barnato, A. E., Sanders, G. D., & Owens, D. K. (2001) · Emerging infectious diseases · doi:10.3201/eid0705.010505 · Cited by 52
Screening for hemochromatosis in children of homozygotes: Prevalence and cost-effectiveness
Adams, P. C., Kertesz, A. E., & VALBERG, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220617 · Cited by 50
Children with Suspected Craniosynostosis: A Cost-Effectiveness Analysis of Diagnostic Strategies
Medina, L. S., Richardson, R. R., & Crone, K. R. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.1.1790215 · Cited by 44
Angus, D. C., Clermont, G., Watson, R. S., Linde‐Zwirble, W. T., Clark, R. H., & Roberts, M. S. (2003) · PEDIATRICS · doi:10.1542/peds.112.6.1351 · Cited by 42
Use of the GlucoWatch® biographer in children and adolescents with diabetes
Eastman, R. C., Chase, H. P., Buckingham, B. A., Hathout, E. H., Fuller-Byk, L., Leptien, A. D., Wyhe, M. M. V., Davis, T. L., Fermi, S. J., Pechler, H., et al. (2002) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2002.30302.x · Cited by 37
König, H., & Barry, J. (2004) · PEDIATRICS · doi:10.1542/peds.113.2.e95 · Cited by 36
Harris, A., Hendrie, D. V., de Klerk, N. H., Bower, C. I., Payne, J., & Stanley, F. J. (1994) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1994.tb138312.x · Cited by 36
Evidence-based health economics
Birch, S., & Birch, S. (2004) · Routledge eBooks · doi:10.4324/9780203493694-8 · Cited by 35
Child health services research. Challenges and opportunities
Forrest, C. B. (1997) · JAMA · doi:10.1001/jama.277.22.1787 · Cited by 34
Bos, J., Rümke, H. C., Welte, R., Postma, M. J., & Jager, J. C. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00254-7 · Cited by 31
BOVIER, P. A., Wyss, K., & Au, H. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00419-5 · Cited by 31
Management of Childhood Lead Poisoning
Glotzer, D. E., Freedberg, K. A., & Bauchner, H. (1995) · Medical Decision Making · doi:10.1177/0272989x9501500104 · Cited by 31
The cost-effectiveness of treatment for congenital diaphragmatic hernia
Poley, M. J., Stolk, E. A., Tibboel, D., Molenaar, J. C., & Busschbach, J. J. V. (2002) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2002.34973 · Cited by 25
Cited by
Crawford, S. E., Ramani, S., Tate, J. E., Parashar, U. D., Svensson, L., Hagbom, M., Franco, M. A., Greenberg, H. B., O'Ryan, M., Kang, G., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.83 · Cited by 687
Solans, M., Pane, S., Estrada, M.-D., Serra-Sutton, V., Berra, S., Herdman, M., Alonso, J., & Rajmil, L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00293.x · Cited by 644
Matza, L. S., Patrick, D. L., Riley, A. W., Alexander, J. J., Rajmil, L., Pleil, A. M., & Bullinger, M. (2013) · Value in Health · doi:10.1016/j.jval.2013.04.004 · Cited by 477
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451
Ravens-Sieberer, U., Erhart, M., Wille, N., Wetzel, R., Nickel, J., & Bullinger, M. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624120-00005 · Cited by 382
Metadata
- Authors
- Griebsch, I., Coast, J., & Brown, J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2005-05-01
- Volume
- 115
- Issue
- 5
- Pages
- e600-e614
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2160883633
- Cited by
- 270
- References
- 49
- FWCI
- 28.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.